Family Medicine

56 year old man presents to clinic for his HME

Julie Blaszczak on Jan 15, 2016

  1. ACC/AHA Release Updated Guideline on the Treatment of Blood Cholesterol to Reduce ASCVD Risk. Am Fam Physician. 2014 Aug 15;90(4):260-265.
  2. Bitzer, R, et. al. Intolerance to Statins: Mechanism and Management. Diabetes Care. 2013;36(supp 2):S325-S330.
  3. Diechmann R, Lavie C, Andrews, S. Coenzyme Q10 and Statin-Induced Mitochondrial Dysfunction. Ochsner J. 2010 Spring;10(1):16–21.
  4. Eckel RH, et. al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology American/Heart Association Task Force on Practice Guidelines. Circulation. 2013;00:000–000.
  5. Gillett RC & Norrell A. Considerations for Safe Use of Statins: Liver Enzyme Abnormalities and Muscle Toxicity. Am Family Physician. 2011;83(6):711-716.
  6. Last AR, Ference JD, Falleroni J. Pharmacologic Treatment of Hyperlipidemia. Am Fam Physician. 2011;84(5):551-558.
  7. Oh RC & Lanier JB. Management of Hypertriglyceridemia. Am Family Physician 2007;75:1365-1372.
  8. Pignone, M. Treatment of lipids (including hypercholesterolemia) in primary prevention. In: UpToDate, Hagberg CA (Ed). UpToDate. (Accessed on January 25, 2016.)
  9. Rosenson, R. Secondary causes of dyslipidemia. In: UpToDate, Hagberg CA (Ed). UpToDate. (Accessed on January 25, 2016.)
  10. Rosenson, R. Treatment of lipids (including hypercholesterolemia) in secondary prevention. In: UpToDate, Hagberg CA (Ed). UpToDate. (Accessed on January 25, 2016.)
  11. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 suppl 2):S9.
  12. Taylor BA et al. A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy. Atherosclerosis. 2015 Feb; 238:329
  13. Underbakke G & McBride P. "Dyslipidemias." Integrative Medicine. Ed. David Rakel. 3rd ed. Philadelphia, PA: Elsevier, 2012. 376-90.

  1. ACC/AHA Release Updated Guideline on the Treatment of Blood Cholesterol to Reduce ASCVD Risk. Am Fam Physician. 2014 Aug 15;90(4):260-265.
  2. Bitzer, R, et. al. Intolerance to Statins: Mechanism and Management. Diabetes Care. 2013;36(supp 2):S325-S330.
  3. Diechmann R, Lavie C, Andrews, S. Coenzyme Q10 and Statin-Induced Mitochondrial Dysfunction. Ochsner J. 2010 Spring;10(1):16–21.
  4. Eckel RH, et. al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology American/Heart Association Task Force on Practice Guidelines. Circulation. 2013;00:000–000.
  5. Gillett RC & Norrell A. Considerations for Safe Use of Statins: Liver Enzyme Abnormalities and Muscle Toxicity. Am Family Physician. 2011;83(6):711-716.
  6. Last AR, Ference JD, Falleroni J. Pharmacologic Treatment of Hyperlipidemia. Am Fam Physician. 2011;84(5):551-558.
  7. Oh RC & Lanier JB. Management of Hypertriglyceridemia. Am Family Physician 2007;75:1365-1372.
  8. Pignone, M. Treatment of lipids (including hypercholesterolemia) in primary prevention. In: UpToDate, Hagberg CA (Ed). UpToDate. (Accessed on January 25, 2016.)
  9. Rosenson, R. Secondary causes of dyslipidemia. In: UpToDate, Hagberg CA (Ed). UpToDate. (Accessed on January 25, 2016.)
  10. Rosenson, R. Treatment of lipids (including hypercholesterolemia) in secondary prevention. In: UpToDate, Hagberg CA (Ed). UpToDate. (Accessed on January 25, 2016.)
  11. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 suppl 2):S9.
  12. Taylor BA et al. A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy. Atherosclerosis. 2015 Feb; 238:329
  13. Underbakke G & McBride P. "Dyslipidemias." Integrative Medicine. Ed. David Rakel. 3rd ed. Philadelphia, PA: Elsevier, 2012. 376-90.

733  views

  0 likes

      0 comments